Elanco Animal Health IncorporatedELANNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank70
3Y CAGR-7.9%
5Y CAGR+254.1%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-7.9%/yr
vs +8.2%/yr prior
5Y CAGR
+254.1%/yr
Recent deceleration
Acceleration
-16.1pp
Decelerating
Percentile
P70
Within normal range
vs 5Y Ago
556.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM15.31%-54.3%
202433.54%+761.4%
2023-5.07%-125.8%
202219.63%+128.7%
20218.59%+31124.5%
20200.03%-99.8%
201915.36%+7.1%
201814.34%+382.8%
20172.97%-62.7%
20167.96%-